Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Estomac / intestins
»
Troubles fonctionnels
18. Novembre 2024
Recherche
Gastroplattform
Troubles fonctionnels
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Diarrhée
MII (maladie de Crohn/colite)
Troubles fonctionnels
Gastroentérite
Hémorragie digestive
Néoplasie
Ulcère peptique
Autres
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 440
Articles 1 - 20 / 8782
Exploring online health resources and self-care among irritable bowel syndrome patients: analyzing internet use and AI chatbot interactions.
Mhealth
Altamimi I, Khan SA, Alhemsi H, Alhumimidi A, Alsulaim KB, Altoom F, Alomri F, Almutairi H, Alshankiti S, Alnobani O, Temsah MH, Jamal AA.
PMID: 39534455 [PubMed]
Water Avoidance-Stress Induces Differential Colon Transcriptomic Responses in BALB/c and C57BL/6 Mice Irritable Bowel Syndrome Model.
Gastro Hep Adv
Pang S, Higgins GA, Wiley JW, Hou X, Lin R, Zheng G.
PMID: 39529650 [PubMed]
Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome.
BMJ Open
Olson JL, Palumbo A, Desjardins C, Wicks C, Bhopa S, Cheyne K, D'Silva A, Graff LA, Narula N, Rodrigues DM, Fernandes A, Marshall DA, Moayyedi P, Presseau J.
PMID: 39521469 [PubMed - indexed for MEDLINE]
Personalisation of therapy in irritable bowel syndrome: a hypothesis.
Lancet Gastroenterol Hepatol
Black CJ, Ford AC.
PMID: 39521004 [PubMed - indexed for MEDLINE]
Dietary management of irritable bowel syndrome: considerations, challenges, and solutions.
Lancet Gastroenterol Hepatol
Whelan K, Ford AC, Burton-Murray H, Staudacher HM.
PMID: 39521003 [PubMed - indexed for MEDLINE]
Practices and Barriers in Implementing the Low FODMAP Diet for Irritable Bowel Syndrome Among Malaysian Dietitians: A Qualitative Study.
Nutrients
Ke TJ, Sameeha MJ, Siah KTH, Jeffri PBQB, Idrus NAB, Krishnasamy S.
PMID: 39519430 [PubMed - indexed for MEDLINE]
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.
J Clin Med
Lopes CM, de Jesus Monteiro CS, Duarte AP, Dos Santos JL.
PMID: 39518476 [PubMed]
Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms.
Mol Cell Biochem
Nakagawa Y, Yamada S.
PMID: 39503802 [PubMed - as supplied by publisher]
A service evaluation of FODMAP restriction, FODMAP reintroduction and long-term follow-up in the dietary management of irritable bowel syndrome.
J Hum Nutr Diet
Foulkes R, Shah P, Twomey A, Dami L, Jones D, Lomer MCE.
PMID: 39498596 [PubMed - as supplied by publisher]
Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome.
Therap Adv Gastroenterol
Khan A, Menon R, Corning B, Cohn S, Kumfa C, Raji M.
PMID: 39493642 [PubMed]
The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT.
PLoS One
König J, Roca Rubio MF, Forsgård RA, Rode J, Axelsson J, Grompone G, Brummer RJ.
PMID: 39485760 [PubMed - indexed for MEDLINE]
Gut microbiota and irritable bowel syndrome: status and prospect.
Front Med (Lausanne)
Cheng X, Ren C, Mei X, Jiang Y, Zhou Y.
PMID: 39484201 [PubMed]
Dietary Interventions in Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes, Microbiota Changes, and Inflammatory Markers.
Cureus
Shams M, Ahmed J, Umar A, Rehman A, Sohail K, Javed B, Mustafa R, Payal F, Shehryar A, Khan M.
PMID: 39483931 [PubMed]
Association Between Stress, Neuroinflammation, and Irritable Bowel Syndrome: The Positive Effects of Probiotic Therapy.
Cell Biochem Funct
Azarfarin M, Moradikor N, Matin S, Dadkhah M.
PMID: 39487668 [PubMed - indexed for MEDLINE]
A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.
Clin Drug Investig
Mokhtare M, Fathi M, Sadeghian AM, Sotoudeheian MJ, Namazi A.
PMID: 39476291 [PubMed - indexed for MEDLINE]
A Cross-Sectional Study of the Prevalence of Irritable Bowel Syndrome and Its Association With Anxiety and Depression Among Nurses in the Al-Qassim Region of Saudi Arabia.
Cureus
Alqifari AN, Alharbi SG, Alayed FM, Alabdullatif NH, Aljardan SA, Alqifari HN.
PMID: 39469355 [PubMed]
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.
Aliment Pharmacol Ther
Goodoory VC, Riggott C, Khasawneh M, Black CJ, Ford AC.
PMID: 39466700 [PubMed - as supplied by publisher]
Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options.
Microorganisms
Pastras P, Aggeletopoulou I, Triantos C.
PMID: 39458345 [PubMed]
Association Between Irritable Bowel Syndrome and Lower Urinary Tract Symptomatology: A Cross-sectional Study in Mexican Population.
J Clin Gastroenterol
Felix-Tellez FA, Del Rio O Brien MF, Ibarra Tapia ME, Escobar Montes MA, Peña Barajas GJ, Mercado Basoco SA, González Gómez FG, Remes-Troche JM, Velarde-Ruiz-Velasco JA.
PMID: 39453697 [PubMed - as supplied by publisher]
The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel syndrome.
Sci Rep
Karpuzcu HC, Turan Erdo, Erdo.
PMID: 39433866 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 8782
Page 1 de 440
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité